Skip to content
Home/Companies/MedTech/Cardiologs Technologies
Cardiologs Technologies

Cardiologs Technologies

MedTech·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Cardiologs Technologies?

Cardiologs Technologies is a French MedTech company, currently owned by Eurazeo since 2019.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Eurazeo
Investor
Eurazeo
Kurma Diagnostics II · 2020 · Healthcare

Key facts

HQFrance
SectorMedTech
Websitecardiologs.com

More from Kurma Diagnostics II

Other portfolio companies in the same fund.

DNA Script
DNA Script
Active
BiotechFrance· 2019
Wandercraft
Wandercraft
Active
MedTechFrance· 2019

More Eurazeo portfolio companies

From the same investor, across funds.

2BSI
Active
ClimateTechFrance
3P
3P
Active
SaaSBelgium
InsuranceDekho
InsuranceDekho
Active
FintechIndia
Malpa
Active
SaaSSpain
Babylon
Babylon
Active
HospitalityFrance· 2026
Fonoa
Active
FintechIreland· 2026

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Cardiologs Technologies?

Cardiologs Technologies is currently owned by Eurazeo, through Kurma Diagnostics II, since 2019.

When did Eurazeo acquire Cardiologs Technologies?

Eurazeo acquired Cardiologs Technologies in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue